Cargando…

Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study

Detalles Bibliográficos
Autores principales:	Drall, Kelsea M., Tun, Hein M., Kozyrskyj, Anita L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302613/ https://www.ncbi.nlm.nih.gov/pubmed/30619776 http://dx.doi.org/10.3389/fcimb.2018.00430

Ejemplares similares

Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
por: Shi, Yichao, et al.
Publicado: (2023)

The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux—A Prospective Longitudinal Interventional Study
por: Castellani, Christoph, et al.
Publicado: (2017)

Infant Vitamin D Supplements, Fecal Microbiota and Their Metabolites at 3 Months of Age in the CHILD Study Cohort
por: Zhao, Xin, et al.
Publicado: (2023)

Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics
por: Ye, Xiaolin, et al.
Publicado: (2023)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Effects of Helicobacter pylori eradication on esophageal motility, esophageal acid exposure, and gastroesophageal reflux disease symptoms
por: Zhao, Tong, et al.
Publicado: (2023)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants
por: Azizollahi, Hamid Reza, et al.
Publicado: (2016)

Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
por: Jo, So Young, et al.
Publicado: (2013)

Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies
por: Wang, Zheng, et al.
Publicado: (2018)

Oral and Fecal Microbiome in Molar-Incisor Pattern Periodontitis
por: Amado, Pâmela Pontes Penas, et al.
Publicado: (2020)

Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
por: Bokoliya, Suresh C., et al.
Publicado: (2021)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
por: Belei, Oana, et al.
Publicado: (2018)

Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
por: Fossmark, Reidar, et al.
Publicado: (2023)

Dysbiotic Fecal Microbiome in HIV-1 Infected Individuals in Ghana
por: Parbie, Prince Kofi, et al.
Publicado: (2021)

Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
por: Lou, Jiamin, et al.
Publicado: (2020)

Characteristics of the fecal microbiome and metabolome in older patients with heart failure and sarcopenia
por: Peng, Jieting, et al.
Publicado: (2023)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Complete Resolution of Pseudomalignant Erosion in a Reflux Gastroesophageal Polyp with Proton Pump Inhibitor
por: Nakajima, Takahiko, et al.
Publicado: (2015)

Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
por: Kim, Sung Eun, et al.
Publicado: (2015)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

“Longitudinal Fecal Microbiome Study of Total Body Irradiated Mice Treated With Radiation Mitigators Identifies Bacterial Associations With Survival”
por: Li, Kelvin, et al.
Publicado: (2021)

Analysis of Porcine Model of Fecal-Induced Peritonitis Reveals the Tropism of Blood Microbiome
por: Hyun, Hwi, et al.
Publicado: (2021)

Gut microbiome and fecal metabolic alteration in systemic lupus erythematosus patients with depression
por: Yao, Han, et al.
Publicado: (2022)

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
por: Abdelbary, Mohamed M. H., et al.
Publicado: (2022)

Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
por: Wang, Jieyi, et al.
Publicado: (2022)

Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
por: Van Dingenen, Lena, et al.
Publicado: (2023)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal Reflux Disease on Postoperative Nausea and Vomiting
por: Kwon, Young Suk, et al.
Publicado: (2020)

The Effect of Alginate in Gastroesophageal Reflux in Infants
por: Salvatore, Silvia, et al.
Publicado: (2018)

Commentary: How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches
por: Jian, Ching, et al.
Publicado: (2021)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Anti-reflux Surgery Versus Proton Pump Inhibitors for Severe Gastroesophageal Reflux Disease: A Cost-Effectiveness Study in Korea
por: Park, Susan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hadb03midrsbcar5pqkvbij6pv